Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of BCD101 in healthy volunteers is currently recruiting for essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BCD101

Snippet

Sponsor: Bichedam Co., Ltd. | Conditions: Essential Hypertension | Phase 1 | Status: RECRUITING